Live feed
Filing
SC 13G
SC 13G0001104659-20-005549·Trillium Therapeutics Inc.
Schedule 13G ownership disclosure
TRILLIUM THERAPEUTICS INC COM NEW
Security class unavailable · CUSIP: 89620X506
Event date: 2020-01-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,790,000
- Percent of class
- 9.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-005549
- Form type
- SC 13G
- Filer
- Trillium Therapeutics Inc.
- CIK
- CIK 1616212
- Filed
- Jan 21, 2020
- Reporting period
- Jan 09, 2020
- Description
- Schedule 13G beneficial ownership